Search results
Results from the WOW.Com Content Network
Skeletal muscle provides a fundamental basis for human function, enabling locomotion and respiration. Muscle wasting is related to poor quality of life and increased morbidity/mortality. Two common but distinct conditions characterized by a loss of skeletal muscle mass are sarcopenia and cachexia. [52]
Muscle atrophy is the loss of skeletal muscle mass. It can be caused by immobility, aging, malnutrition, medications, or a wide range of injuries or diseases that impact the musculoskeletal or nervous system. Muscle atrophy leads to muscle weakness and causes disability.
People with spinal muscle atrophy (SMA), an inherited neuromuscular disease, usually experience muscle weakness that impacts movement. New research suggests that electrical spinal cord stimulation ...
Deficiency of BNIP3 leads to muscle inflammation and atrophy. [19] Furthermore, not every muscle is as susceptible to the atrophic effects of aging. For example, in both humans [20] and mice [21] it has been shown that lower leg muscles are not as susceptible to aging as upper leg muscles. This could perhaps be explained by the differential ...
ShutterstockRegaining muscle and strength after a period of inactivity or injury can be a challenging journey, but with the right workouts, dedication, and consistency, it's entirely achievable.
Cachexia (/ k ə ˈ k ɛ k s i ə / [1]) is a syndrome that happens when people have certain illnesses, causing muscle loss that cannot be fully reversed with improved nutrition. [2] It is most common in diseases like cancer, congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease, and AIDS.
In medicine, wasting, also known as wasting syndrome, refers to the process by which a debilitating disease causes muscle and fat tissue to "waste" away. Wasting is sometimes referred to as "acute malnutrition" because it is believed that episodes of wasting have a short duration, in contrast to stunting , which is regarded as chronic malnutrition.
Myostatin inhibitors are a class of drugs that work by blocking the effect of myostatin, which inhibits muscle growth. In animal models and limited human studies, myostatin inhibitors have increased muscle size. They are being developed to treat obesity, sarcopenia, muscular dystrophy, and other illnesses.